SRX Health Solutions Q2 revenue rises, EBITDA loss narrows

SRx Global

14/05/2026 21:32

Overview

US pet health and wellness firm's fiscal Q2 revenue rose 23% sequentially to $3.4 mln

Adjusted EBITDA loss improved about 44% quarter over quarter to around $0.6 mln

Company ended Q2 with $20.5 mln in cash, up from $1.3 mln at prior fiscal year end

Outlook

Company expects to close EMJX acquisition before end of fiscal third qtr

SRX Health Solutions advancing AI-enabled analytics and digital treasury management initiatives

Company focused on disciplined capital allocation and scalable long-term growth

Result Drivers

INVENTORY AVAILABILITY AND HALO PLATFORM - Co said sequential revenue and profit improvement reflected restored inventory and renewed momentum on the Halo platform

CRYPTOCURRENCY STRATEGY - Co said its active cryptocurrency strategy outperformed the market and reduced losses compared to a buy-and-hold approach

Company press release: ID:nGNX8MPkKx

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
$3.44 mln
Q2 Net Income
-$6.38 mln
Q2 Adjusted EBITDA
-$594,000
Q2 Gross Margin
37.00%
Q2 Gross Profit
$1.28 mln
Q2 Operating Income
-$1.80 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)